Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.

  title={Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.},
  author={John M. Bertoni and John Philip Arlette and Hubert Henery Fernandez and Cheryl J. Fitzer-Attas and Karen P Frei and Mohamed Nour Hassan and Stuart H. Isaacson and Mark F. Lew and Eric Steven Molho and William G. Ondo and Tania J Phillips and Carlos Singer and James P Sutton and John E. Wolf},
  journal={Archives of neurology},
  volume={67 3},
OBJECTIVE To evaluate the possible association of Parkinson disease (PD) and melanoma in North America. DESIGN, SETTING, AND PATIENTS Thirty-one centers enrolled patients with idiopathic PD. At visit 1, a neurologist obtained a medical history. At visit 2, a dermatologist recorded melanoma risk factors, performed a whole-body examination, and performed a biopsy of lesions suggestive of melanoma for evaluation by a central dermatopathology laboratory. We compared overall prevalence of melanoma… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 33 extracted citations


Publications referenced by this paper.
Showing 1-10 of 20 references

Evaluation of Parkinson’s disease (PD) prevalence in patients with malignant melanoma (MM) [abstract

  • DS Rigel, Z Patel, J Bolognia
  • Mov Disord
  • 2006
1 Excerpt

Similar Papers

Loading similar papers…